The AJMC® Medicare compendium is a comprehensive resource for clinical news and expert insights on issues that affect Medicare beneficiaries with a focus on polypharmacy, reimbursement challenges, and other topics related to seniors.

Study Finds High Polypharmacy Rates Among Those With History of Depression

January 24th 2022, 6:30pm


Results of a study carried out in Iran found those with a recent history of depressive disorders were more likely to suffer from polypharmacy, or taking 5 or more medications concurrently.

What We’re Reading: Unvaccinated Seniors at Higher Risk for Hospitalization, Nursing Homes in Crisis; Alzheimer Groups Protest

January 21st 2022, 3:42pm


Unvaccinated older adults are 49 times more likely to be hospitalized after contracting COVID-19; nursing homes are experiencing a major staffing crisis; major Alzheimer groups plan to meet with federal officials and lawmakers to protest the CMS drug proposal.

Polypharmacy Linked With Rehospitalization, Death Among Patients With HF

January 19th 2022, 5:40pm


An analysis conducted in Japan among patients with acute decompensated heart failure (HF) revealed excessive polypharmacy at hospital discharge is associated with an increased risk of mortality after 1 year.

Contributor: Technology-Based Telepharmacy Needed to Engage High-risk Patients, Improve Medication Adherence

January 16th 2022, 12:00pm


Medicare Advantage plans must leverage data-driven insights and omnichannel telepharmacy software to guide meaningful interactions with high-risk members and boost Star Ratings performance.

Medicine Review Reduces Polypharmacy in Older Adults

January 14th 2022, 10:40pm


The randomized study consisted of an intervention delivered by general practitioners in the Republic of Ireland.

CMS Says It Will Limit Biogen’s AD Drug for Patients in Clinical Trials

January 11th 2022, 10:30pm


In a National Coverage Determination decision memo released Tuesday, CMS said it will gather public comment for 30 days about its plan to limit coverage for Alzheimer disease (AD) biologics that target plaque buildup in the brain to patients enrolled in certain clinical trials.

Increased Patient-Physician Dialogue in EDs May Reduce Polypharmacy in Older Patients

January 8th 2022, 2:00pm


A Danish study observed emergency department (ED) health care providers and identified 5 factors that could play into patient involvement in medication discussions, particularly in older patients with polypharmacy.

CMS Seeks to Pass Part D Price Reductions to Beneficiaries

January 7th 2022, 5:00pm


CMS proposed rulemaking Thursday that would pass pharmaceutical price concessions to beneficiaries in Medicare Part D plans and make the medical loss ratio in Medicare Advantage plans more robust.

Most-Read AJAC Papers of 2021

December 27th 2021, 2:30pm


The most-read AJAC papers of 2021 analyze real-world programs to transform health care and provide insight into physician perspectives of health care and insurance.

Top 5 Most-Read Medicare Articles of 2021

December 25th 2021, 1:00pm


This year’s most-read articles on Medicare covered topics including accountable care organizations, value-based payment, and star ratings.